Overview

A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
To characterize the phenotype in patients with Morton's neuroma and to explore the effect of local administration of Xylocaine (lidocaine)
Phase:
Early Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Lidocaine